Literature DB >> 1530792

Localization of the immunologic activity in the superantigen Staphylococcal enterotoxin B using truncated recombinant fusion proteins.

R Buelow1, R E O'Hehir, R Schreifels, T J Kummerehl, G Riley, J R Lamb.   

Abstract

The exotoxins of certain strains of Staphylococcus aureus strains are able both to stimulate potent proliferation and induce anergy in T lymphocytes expressing the appropriate T cell Ag receptor V beta gene elements. Although T cell activation by the S. aureus enterotoxins requires the presence of accessory cells bearing class II Ag of the MHC, unlike the peptide fragments of nominal Ag, they contact the external surfaces of both the class II MHC and TCR molecules. This paper investigates the immunologically active domains of S. aureus enterotoxin B (SEB) using truncated fragments of rSEB expressed as a fusion protein with protein A. The results of the experiments reported here indicate that the minimal fragment of SEB able to stimulate and induce anergy in hemagglutinin-reactive human T cells expressing V beta 3.1 gene elements is located in the amino-terminal portion of the molecule within residues 1-138. Deletion of the first 30 amino acid residues renders rSEB unable to stimulate T cells expressing V beta 3.1, whereas polyclonal T cells still respond to this molecule. This implies that the stimulation of several TCR-V beta families may be caused by the interaction with different regions of the toxin. The localization of immunologically active sites in the bacterial enterotoxins is needed to investigate both their biology and potential application as immunomodulatory agents.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530792

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Mapping of staphylococcal enterotoxin A functional binding sites and presentation by monoclonal antibodies and fusion proteins.

Authors:  W Mahana
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Peptide antagonists of superantigen toxins.

Authors:  Raymond Kaempfer
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

Review 3.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

4.  Biological activities of staphylococcal enterotoxin type A mutants with N-terminal substitutions.

Authors:  T O Harris; M J Betley
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

5.  Concomitant loss of conformation and superantigenic activity of staphylococcal enterotoxin B deletion mutant proteins.

Authors:  B Metzroth; T Marx; M Linnig; B Fleischer
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

6.  Localization of binding sites of staphylococcal enterotoxin B (SEB), a superantigen, for HLA-DR by inhibition with synthetic peptides of SEB.

Authors:  J L Komisar; S Small-Harris; J Tseng
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

7.  Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1.

Authors:  M L Hoffmann; L M Jablonski; K K Crum; S P Hackett; Y I Chi; C V Stauffacher; D L Stevens; G A Bohach
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Identification of staphylococcal enterotoxin B sequences important for induction of lymphocyte proliferation by using synthetic peptide fragments of the toxin.

Authors:  M Jett; R Neill; C Welch; T Boyle; E Bernton; D Hoover; G Lowell; R E Hunt; S Chatterjee; P Gemski
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins.

Authors:  T O Harris; D Grossman; J W Kappler; P Marrack; R R Rich; M J Betley
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  Staphylococcal enterotoxin type A internal deletion mutants: serological activity and induction of T-cell proliferation.

Authors:  T O Harris; W O Hufnagle; M J Betley
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.